Comparison of pre-operative and post-operative radiotherapy in patients with localized myxoid liposarcoma

Author:

Masunaga Tomoya1,Tsukamoto Shinji1ORCID,Honoki Kanya1,Fujii Hiromasa1,Kido Akira2ORCID,Akahane Manabu3,Tanaka Yasuhito1,Mavrogenis Andreas F4,Errani Costantino5,Kawai Akira6

Affiliation:

1. Nara Medical University Department of Orthopaedic Surgery, , Nara , Japan

2. Nara Medical University Department of Rehabilitation Medicine, , Nara , Japan

3. National Institute of Public Health Department of Health and Welfare Services, , Saitama , Japan

4. National and Kapodistrian University of Athens, School of Medicine First Department of Orthopaedics, , Athens , Greece

5. IRCCS Istituto Ortopedico Rizzoli Department of Orthopaedic Oncology, , Bologna , Italy

6. National Cancer Center Hospital Division of Musculoskeletal Oncology, , Tokyo , Japan

Abstract

Abstract Background Myxoid liposarcoma is more radiosensitive than other soft tissue sarcomas, and radiotherapy has been reported to reduce tumour size. This study was performed to compare the rates of local recurrence, survival and wound complications between pre- and post-operative radiotherapy for localized myxoid liposarcoma. Methods From the Japanese Nationwide Bone and Soft Tissue Tumor Registry database, 200 patients with localized myxoid liposarcoma who received pre- (range, 30–56 Gy) or post-operative (range, 45–70 Gy) radiotherapy and surgery were included in this retrospective study. Propensity score matching was used to adjust for background differences between patients who received pre- and post-operative radiotherapy. Results Local recurrence occurred in five (5.0%) and nine (9.0%) patients in the pre- and post-operative radiotherapy groups, respectively (both n = 100). The median follow-up time from diagnosis was 40.5 months (IQR, 26.3–74). Univariate analysis showed a similar risk of local recurrence between the pre- and post-operative radiotherapy groups (5-year local recurrence-free survival 94.9% [95% CI 87.0–98.1] vs. 89.0% [95% CI 79.6–94.3]; P = 0.167). Disease-specific survival was similar between the pre- and post-operative radiotherapy groups (5-year disease-specific survival 88.1% [95% CI 75.5–94.6] vs. 88.4% [95% CI 77.3–94.5]; P = 0.900). The incidence of wound complications was similar between the pre- and post-operative radiotherapy groups (7.0% vs. 12.0%; P = 0.228). Conclusions There was no difference in local recurrence, survival or incidence of wound complications between pre- and post-operative radiotherapy for localized myxoid liposarcoma. Therefore, pre-operative radiotherapy for myxoid liposarcoma provides clinical results equivalent to post-operative radiotherapy.

Funder

Grant of Japan Orthopaedics and Traumatology Research Foundation

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference50 articles.

1. Specificity of TLS-CHOP rearrangement for classic myxoid/round cell liposarcoma: absence in predominantly myxoid well-differentiated liposarcomas;Antonescu;J Mol Diagn,2000

2. Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases;Antonescu;Clin Cancer Res,2001

3. Fusion of the EWS and CHOP genes in myxoid liposarcoma;Panagopoulos;Oncogene,1996

4. Additional evidence of a variant translocation t(12;22) with EWS/CHOP fusion in myxoid liposarcoma: clinicopathological features;Dal Cin;J Pathol,1997

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3